111 related articles for article (PubMed ID: 8157364)
1. Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model.
Chignola R; Foroni R; Candiani C; Franceschi A; Pasti M; Stevanoni G; Anselmi C; Tridente G; Colombatti M
Int J Cancer; 1994 Apr; 57(2):268-74. PubMed ID: 8157364
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.
Chignola R; Foroni R; Franceschi A; Pasti M; Candiani C; Anselmi C; Fracasso G; Tridente G; Colombatti M
Br J Cancer; 1995 Sep; 72(3):607-14. PubMed ID: 7669569
[TBL] [Abstract][Full Text] [Related]
3. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.
Colombatti M; Dell'Arciprete L; Chignola R; Tridente G
Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human glioma cells to cytotoxic heteroconjugates.
Colombatti M; Bisconti M; Dell'Arciprete L; Gerosa MA; Tridente G
Int J Cancer; 1988 Sep; 42(3):441-8. PubMed ID: 3138194
[TBL] [Abstract][Full Text] [Related]
5. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
8. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
Wenning LA; Murphy RM
Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
[TBL] [Abstract][Full Text] [Related]
9. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin.
Candiani C; Tommasi M; Fracasso G; Lorenzetti I; Adami A; Benoni G; Tridente G; Colombatti M
Life Sci; 2001 Jun; 69(3):335-46. PubMed ID: 11441924
[TBL] [Abstract][Full Text] [Related]
11. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.
Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF
J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254
[TBL] [Abstract][Full Text] [Related]
14. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
Dosio F; Franceschi A; Ceruti M; Brusa P; Cattel L; Colombatti M
Biochem Pharmacol; 1996 Jul; 52(1):157-66. PubMed ID: 8678901
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
Engebraaten O; Hjortland GO; Juell S; Hirschberg H; Fodstad O
Int J Cancer; 2002 Feb; 97(6):846-52. PubMed ID: 11857366
[TBL] [Abstract][Full Text] [Related]
18. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
19. Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures.
Chignola R; Anselmi C; Dalla Serra M; Franceschi A; Fracasso G; Pasti M; Chiesa E; Lord JM; Tridente G; Colombatti M
J Biol Chem; 1995 Oct; 270(40):23345-51. PubMed ID: 7559491
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme.
Hall WA; Godal A; Juell S; Fodstad O
J Neurosurg; 1992 May; 76(5):838-44. PubMed ID: 1314294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
